Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Blackhawk Growth Corp BLRZF


Primary Symbol: C.BLR Alternate Symbol(s):  C.BLR.WT

Blackhawk Growth Corp. is a Canada-based investment holding company. The Company invests in equity and debt instruments of companies to generate positive returns for shareholders. It focuses on investing in multiple companies across a variety of sectors across North America. The Company has focused its investments on the health, cannabis and cannabidiol (CBD) industries, in both Canada and the United States.


CSE:BLR - Post by User

Comment by Loonyon Feb 16, 2024 10:09pm
67 Views
Post# 35885452

RE:Australian Hardenbrook Acquisition 5+ Months Pending...

RE:Australian Hardenbrook Acquisition 5+ Months Pending...BLR=$1.17MCAD. Hardenbrook $4.6MAUD. GLTA!

Blackhawk Growth
Mkt cap 1.17M



Blackhawk Growth Corp. entered into a share purchase agreement to acquire Hardenbrook Group Pty Ltd for AUD 4.6 million.

May 28, 2023
https://www.marketscreener.com/quote/stock/BLACKHAWK-GROWTH-CORP-154280462/news/Blackhawk-Growth-Corp-entered-into-a-share-purchase-agreement-to-acquire-Hardenbrook-Group-Pty-Ltd-43985499/


https://www.thenewswire.com/press-releases/1AMqFbJYP-blackhawk-growth-announces-the-acquisition-of-hardenbrook-and-board-changes.html

Hardenbrook has cash and cash equivalents of $800,000 plus 4 portfolio subsidiaries in sectors of Heathcare AI, BioPharma, and AgriTech. Hardenbrook also owns 1,340,000 shares in MindBio Therapeutics Corp (CSE: MBIO) and is excited by the prospects of the two Phase 2 clinical trials and is looking forward to the additional seven Phase 1 results due this year. It will continue to hold MindBio shares. Hardenbrook’s balance sheet will help recapitalize Blackhawk’s balance sheet and provide a pathway for growth. Hardenbrook is also progressing all 4 of its portfolio companies simultaneously towards a spin out and listing. More information on Hardenbrook and its portfolio can be seen here https://www.hardenbrook.group.
<< Previous
Bullboard Posts
Next >>